why choose us

300×250 Ad Slot

Research Article: The Inhibition of Evolocumab on Non-Infarct-Related Artery Disease in Patients with ST-Elevation Myocardial Infarction

Date Published: 2023-06-30

Introduction:
Although there are currently a variety of therapeutic measures existing for patients with atherosclerotic cardiovascular disease (ASCVD), including lipid-lowering therapy, anti-inflammatory therapy, antiplatelet therapy and revascularization, recurrent cardiovascular events are still common and lead to substantial morbidity. , Substantial evidence has suggested that low density lipoprotein (LDL-C) lowering treatment is effective in reducing mortality in patients with ASCVD. , As we know, for patients with acute…

Read more

300×250 Ad Slot